Our results revealed that the tumor‐conditioned medium (TCM) from HCC cells in the METTL3‐knockdown groups showed increased capacity to stimulate HUVEC tube formation compared to the control groups (Fig 2K and K‐1). The gene discussed is METTL3; the disease is hepatocellular carcinoma.